- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Active Biotech AB (ACTI)
The Active Biotech share price today is 0.062, view ST ACTI stock exchange data. Track the latest Active Biotech share price with real-time updates on ACTI stock performance including market cap, day range, 52-week range and dividend yield. Access ACTI charts, earnings dates and analyst estimates to support your investment decisions.
Stockholm
Currency in SEK
0.062
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.061
0.069
52 wk Range
0.037
0.340
ACTI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0610.069
52 wk Range
0.0370.340
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ACTI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
Earnings
Latest Release
07-05-2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
Compare ACTI to Peers and Sector
Metrics to compare | ACTI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipACTIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.2x | −2.5x | −0.5x | |
PEG Ratio | −0.06 | −0.07 | 0.00 | |
Price/Book | 2.8x | 2.8x | 2.6x | |
Price / LTM Sales | - | 15.1x | 3.2x | |
Upside (Analyst Target) | - | 129.3% | 50.4% | |
Fair Value Upside | Unlock | 13.3% | 7.2% | Unlock |
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.
Ownership
Ownership Overview
FAQ
What Is the Active Biotech (ACTI) Share Price Today?
The Active Biotech share price today is 0.062.
What is the current Active Biotech (ACTI) share price and day range?
As of 15-05-2026, the Active Biotech share price is 0.062, with a previous close of 0.063. The share price has ranged from 0.061 to 0.069 today, while the 52-week range spans from 0.037 to 0.340.
What Is the Active Biotech Market Cap?
As of today, Active Biotech market cap is 164.490M.
What Is the Active Biotech (ACTI) Share Price Target?
The average 12-month share price target for Active Biotech is 0.250, with a high estimate of 0.25 and a low estimate of 0.25. 0 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +303.23% Upside potential.
What Is Active Biotech's Earnings Per Share (TTM)?
The Active Biotech EPS (TTM) is -0.022.
When Is the Next Active Biotech Earnings Date?
Active Biotech will release its next earnings report on 08-05-2026.
From a Technical Analysis Perspective, Is ACTI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Active Biotech Trade On?
Active Biotech is listed and trades on the Stockholm Stock Exchange.
What Is the Stock Symbol for Active Biotech?
The stock symbol for Active Biotech is "ACTI."
How Many Times Has Active Biotech Stock Split?
Active Biotech has split 10 times.
How Many Employees Does Active Biotech Have?
Active Biotech has 5 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.